Background: Persons with opioid use disorder (OUD) represent an estimated 4-11% of hospitalized patients and are increasingly admitted for opioid-related complications. In response to the opioid epidemic, national organizations have recommended hospitals develop protocols to engage patients with OUD in opioid agonist treatment (OAT) during hospitalization. Buprenorphine is an effective OAT for OUD that is [...]